Kontafarma China Holdings Limited (01312) has submitted its monthly return for the period ended 31 October 2025. There was no change in the authorized share capital, which remains at 100,000,000,000 ordinary shares at a par value of HKD 0.002 per share. The total authorized share capital remains HKD 200,000,000.

The total number of issued shares (excluding treasury shares) also showed no change, standing at 5,588,571,777 shares. The report further confirms no issuance or movement in share options, warrants, or other convertible instruments during the month.